Works matching IS 00070920 AND DT 2020 AND VI 122 AND IP 10

Results: 20

Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer.

Published in:

2020

By:

Barisciano, Giovannina;
Colangelo, Tommaso;
Rosato, Valeria;
Muccillo, Livio;
Taddei, Maria Letizia;
Ippolito, Luigi;
Chiarugi, Paola;
Galgani, Mario;
Bruzzaniti, Sara;
Matarese, Giuseppe;
Fassan, Matteo;
Agostini, Marco;
Bergamo, Francesca;
Pucciarelli, Salvatore;
Carbone, Annalucia;
Mazzoccoli, Gianluigi;
Colantuoni, Vittorio;
Bianchi, Fabrizio;
Sabatino, Lina

Publication type:

corrected article

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential.

Published in:

2020

By:

Tsui, Yu-Man;
Chan, Lo-Kong;
Ng, Irene Oi-Lin

Publication type:

journal article

Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom).

Published in:

2020

By:

Renehan, Andrew G.;
Pegington, Mary;
Harvie, Michelle N.;
Sperrin, Matthew;
Astley, Susan M.;
Brentnall, Adam R.;
Howell, Anthony;
Cuzick, Jack;
Gareth Evans, D.

Publication type:

journal article

Adherence to the WCRF/AICR 2018 recommendations for cancer prevention and risk of cancer: prospective cohort studies of men and women.

Published in:

2020

By:

Kaluza, Joanna;
Harris, Holly R.;
Håkansson, Niclas;
Wolk, Alicja

Publication type:

journal article

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis.

Published in:

2020

By:

Li, Ruochen;
Liu, Hao;
Cao, Yifan;
Wang, Jieti;
Chen, Yifan;
Qi, Yangyang;
Lv, Kunpeng;
Liu, Xin;
Yu, Kuan;
Lin, Chao;
Zhang, Heng;
He, Hongyong;
Li, He;
Chen, Lingli;
Shen, Zhenbin;
Qin, Jing;
Zhang, Weijuan;
Sun, Yihong;
Xu, Jiejie

Publication type:

journal article

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

Published in:

2020

By:

Ohmura, Hirofumi;
Yamaguchi, Kyoko;
Hanamura, Fumiyasu;
Ito, Mamoru;
Makiyama, Akitaka;
Uchino, Keita;
Shimokawa, Hozumi;
Tamura, Shingo;
Esaki, Taito;
Mitsugi, Kenji;
Shibata, Yoshihiro;
Oda, Hisanobu;
Tsuchihashi, Kenji;
Ariyama, Hiroshi;
Kusaba, Hitoshi;
Oda, Yoshinao;
Akashi, Koichi;
Baba, Eishi

Publication type:

journal article

Ferritin in glioblastoma.

Published in:

2020

By:

Jaksch-Bogensperger, Heidi;
Spiegl-Kreinecker, Sabine;
Arosio, Paolo;
Eckl, Peter;
Golaszewski, Stefan;
Ebner, Yvonne;
Al-Schameri, Rahman;
Strasser, Peter;
Weis, Serge;
Bresgen, Nikolaus

Publication type:

journal article

DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.

Published in:

2020

By:

Wu, Chaofan;
Ding, Hui;
Wang, Shuochen;
Li, Yangxin;
Liu, Song-Bai;
Wang, Xiaoxiao;
Zheng, Jiqing;
Xue, Ting;
Amin, Hesham M.;
Song, Yao-Hua;
Zhou, Jin

Publication type:

journal article

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.

Published in:

2020

By:

Stremitzer, Stefan;
Vermeulen, Peter;
Graver, Shannon;
Kockx, Mark;
Dirix, Luc;
Yang, Dongyun;
Zhang, Wu;
Stift, Judith;
Wrba, Friedrich;
Gruenberger, Thomas;
Lenz, Heinz-Josef;
Scherer, Stefan J.

Publication type:

journal article

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers.

Published in:

2020

By:

Okadome, Kazuo;
Baba, Yoshifumi;
Nomoto, Daichi;
Yagi, Taisuke;
Kalikawe, Rebecca;
Harada, Kazuto;
Hiyoshi, Yukiharu;
Nagai, Yohei;
Ishimoto, Takatsugu;
Iwatsuki, Masaaki;
Iwagami, Shiro;
Miyamoto, Yuji;
Yoshida, Naoya;
Watanabe, Masayuki;
Komohara, Yoshihiro;
Shono, Takashi;
Sasaki, Yutaka;
Baba, Hideo

Publication type:

journal article

A novel stratification framework for predicting outcome in patients with prostate cancer.

Published in:

2020

By:

Luca, Bogdan-Alexandru;
Moulton, Vincent;
Ellis, Christopher;
Edwards, Dylan R.;
Campbell, Colin;
Cooper, Rosalin A.;
Clark, Jeremy;
Brewer, Daniel S.;
Cooper, Colin S.

Publication type:

journal article

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.

Published in:

2020

By:

Toss, Michael S.;
Abidi, Asima;
Lesche, Dorothea;
Joseph, Chitra;
Mahale, Sakshi;
Saunders, Hugo;
Kader, Tanjina;
Miligy, Islam M.;
Green, Andrew R.;
Gorringe, Kylie L.;
Rakha, Emad A.

Publication type:

journal article

A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma.

Published in:

2020

By:

Bierbrauer, Annika;
Jacob, Maureen;
Vogler, Meike;
Fulda, Simone

Publication type:

journal article

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Published in:

2020

By:

Usher-Smith, J. A.;
Harshfield, A.;
Saunders, C. L.;
Sharp, S. J.;
Emery, J.;
Walter, F. M.;
Muir, K.;
Griffin, S. J.

Publication type:

corrected article

Comments on "Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study".

Published in:

2020

By:

Taherifard, Erfan

Publication type:

Letter

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.

Published in:

2020

By:

Xu, Zhihong;
Pang, Tony C. Y.;
Liu, Adele C.;
Pothula, Srinivasa P.;
Mekapogu, Alpha Raj;
Perera, Chamini J.;
Murakami, Takashi;
Goldstein, David;
Pirola, Romano C.;
Wilson, Jeremy S.;
Apte, Minoti V.

Publication type:

journal article

Tumour-agnostic drugs in paediatric cancers.

Published in:

2020

By:

Chisholm, Julia C.;
Carceller, Fernando;
Marshall, Lynley V.

Publication type:

journal article

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.

Published in:

2020

By:

Liu, Jun;
Hong, Junshik;
Han, Heejoo;
Park, Jihyun;
Kim, Dongchan;
Park, Hyejoo;
Ko, Myunggon;
Koh, Youngil;
Shin, Dong-Yeop;
Yoon, Sung-Soo

Publication type:

journal article

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.

Published in:

2020

By:

Eiger, Daniel;
Pondé, Noam F.;
Agbor-Tarh, Dominique;
Moreno-Aspitia, Alvaro;
Piccart, Martine;
Hilbers, Florentine S.;
Werner, Olena;
Chumsri, Saranya;
Dueck, Amylou;
Kroep, Judith R.;
Gomez, Henry;
Láng, István;
Rodeheffer, Richard J.;
Ewer, Michael S.;
Suter, Thomas;
de Azambuja, Evandro

Publication type:

journal article

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.

Published in:

2020

By:

Gridelli, Cesare;
Ciuleanu, Tudor;
Domine, Manuel;
Szczesna, Aleksandra;
Bover, Isabel;
Cobo, Manuel;
Kentepozidis, Nikolaos;
Zarogoulidis, Konstantinos;
Kalofonos, Charalabos;
Kazarnowisz, Andrzej;
Korozan, Magdalena;
de las Penas, Ramon;
Majem, Margarita;
Chella, Antonio;
Griesinger, Frank;
Bournakis, Evangelos;
Sadjadian, Parvis;
Kotsakis, Athanasios;
Chinet, Thierry;
Syrigos, Kostantinos N.

Publication type:

journal article

Works matching IS 00070920 AND DT 2020 AND VI 122 AND IP 10

Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer.

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential.

Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom).

Adherence to the WCRF/AICR 2018 recommendations for cancer prevention and risk of cancer: prospective cohort studies of men and women.

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103<sup>+</sup>CD8<sup>+</sup> T cells conferring favourable prognosis.

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

Ferritin in glioblastoma.

DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers.

A novel stratification framework for predicting outcome in patients with prostate cancer.

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.

A direct comparison of selective BH3-mimetics reveals BCL-X<sub>L</sub>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma.

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Comments on "Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study".

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.

Tumour-agnostic drugs in paediatric cancers.

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.